WO1998030617A1 - Hydrogels - Google Patents

Hydrogels Download PDF

Info

Publication number
WO1998030617A1
WO1998030617A1 PCT/GB1998/000068 GB9800068W WO9830617A1 WO 1998030617 A1 WO1998030617 A1 WO 1998030617A1 GB 9800068 W GB9800068 W GB 9800068W WO 9830617 A1 WO9830617 A1 WO 9830617A1
Authority
WO
WIPO (PCT)
Prior art keywords
polyol
polyester
water
polyesters
reaction
Prior art date
Application number
PCT/GB1998/000068
Other languages
French (fr)
Inventor
Richard John Searle
Original Assignee
Smith & Nephew Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew Plc filed Critical Smith & Nephew Plc
Priority to AU55665/98A priority Critical patent/AU5566598A/en
Publication of WO1998030617A1 publication Critical patent/WO1998030617A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66Polyesters containing oxygen in the form of ether groups
    • C08G63/668Polyesters containing oxygen in the form of ether groups derived from polycarboxylic acids and polyhydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145Hydrogels or hydrocolloids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds

Definitions

  • the present invention relates to hydrogels.
  • the present invention relates to polyester hydrogels.
  • Polyesters of succinic acid are known from US Patent No.3, 883,901. Such polyesters are the reaction product of a succinate ester, such as diethyl succinate, and a glycol, such as polyethylene glycol.
  • polyesters produced by reacting succinic anhydride with a polyol containing three or more hydroxy groups are novel and advantageous.
  • polyester comprising residues of succinic acid and a polyol containing three or more hydroxy groups.
  • a water swellable hydrogel comprising a polyester which polyester comprises residues of succinic acid and a polyol containing three or more hydroxy groups.
  • a water swellable hydrogel a three- dimensional network of a super absorbent polymer which interacts with aqueous solutions by swelling and retains a significant proportion of water within its structure.
  • a super absorbent polymer is understood to mean a polymer which is capable of having an equilibrium water content of at least 30% w/w.
  • M n number average molecular weight
  • the high molecular weight polyesters of the invention are also advantageous over prior art polyesters in that they exhibit crosslinking.
  • cross-linked polyester of succinic anhydride and a polyol eg. a cross-linked polyester comprising residues of succinic acid and a polyol containing three or more hydroxy groups.
  • Such cross-linked copolyesters generally act as hydrogels.
  • poiyols containing three or more hydroxy groups known per se are suitable for use in the present invention.
  • Such poiyols include, for example, polyether poiyols or polyhydroxyalkanes. It should be noted that the poiyols for use in the present invention should not be limited to the polyether poiyols or the polyhydroxyalkanes.
  • n is a number from 3 to 6
  • polyester of the invention are suitable for the preparation of the polyester of the invention and include, for example, glycerol, sorbitol, mannitol, adonite, ribite, dulcitol, erythritol and xylite.
  • Poiyols such as triols which may be mentioned include trihydroxyaikanes such as glycerol.
  • polyether poiyols examples include those sold under the range of TP30 by Perstorp.
  • polyesters of the invention may be prepared using conventional methods known per se.
  • the method of manufacturing a polyester according to the invention may optionally include the use of a catalyst.
  • Preferred catalysts are acid catalysts and especially protic acid catalysts.
  • Particular protic acid catalysts which may be mentioned include sulphuric acid, methane sulphonic acid and p-toluene sulphonic acid.
  • the ratios of the succinic anhydride and the polyol in the polymerisation reaction will depend upon, inter alia, the functionality of the polyol, that is, the number of free hydroxy groups and the degree of cross-linking required in the resulting polyester.
  • succinic anhydride has a functionality of 2
  • glycerol which has two primary and one secondary hydroxy group is also considered to possess a functionality of 2 since the secondary hydroxy is less reactive than the primary hydroxy groups.
  • the ratio of succinic anhydride to polyol should be from 0.7:1 to 1 :1.3, preferably 1 :1.
  • a polyester of succinic anhydride and a trioi such as glycerol should comprise preferably 3 units of succinic anhydride to 2 units of glycerol, eg. giving a preferred functionality ratio of 1 :1.
  • Polyesters according to the invention may be characterised using conventional techniques known per se, such as infra red spectroscopy, nmr, rheological measurements, glass transition measurements and water uptake.
  • the polyesters according to the invention are particularly advantageous in that they are biodegradable.
  • they may be useful in preparing biodegradable implants such as medical or surgical prostheses, supports for such prostheses, supports for cell cultures such as may be used in ligament, cartilage or tendon repair, supports for cell cultures in woundcare or as woundcare agents in their own right, eg. debnding agents, pharmaceutical carriers etc. or the copolyesters of the invention may be useful in imaging during interventional procedures.
  • polyesters of the invention are also advantageous in that they are sterilisable. Any conventional form of sterilisation may be used, eg. steam sterilisation, but an especial benefit of the polyesters of the invention is that they may be sterilised without detrimental effect by x-radiation.
  • Polyesters produced from succinic anhydride and diols are known in the prior art to be useful as bioresorbable sutures. Experimental results indicate that such polyesters, as well as the polyesters of the present invention may be especially useful in wound healing, eg. as a debriding agent.
  • a polyester comprising residues of succinic anhydride and a polyol in the manufacture of a wound healing agent, eg. a debriding agent.
  • a method of wound healing which comprises applying a polyester comprising residues of succinic acid and a polyol to the wound of a patient.
  • the desiccator was heated in an oven at 80° for 5 to 15 mins with the tap open. It was then heated with the tap closed for a further 15 to 16 hrs at 80°. The resulting materials were heated in a vacuum oven at 70°.
  • a second series of materials were prepared containing various levels of glycerol and TP30.
  • the formulations are shown in Table IV.
  • Table V shows the degrees of conversion p(CooH) for these materials, calculated using the method shown below.
  • c) is assumed to be negligible since the anhydride is stored under nitrogen, though any water absorbed would convert the anhydride to succinic acid and would therefore manifest itself as an error in b). This water would in fact be liberated during the reaction, d) is assumed to be negligible since the reaction is carried out in a sealed system in the presence of a drying agent, followed by vacuum treatment.
  • m a is the mass of the anhydride in the mixture (during the initial mixing procedure)
  • m r is the total mass of mixture poured onto the release paper
  • M a is the molecular mass of succinic anhydride.
  • Figure 1 shows the percentage weight gain of the materials prepared without glycerol in both deionised water and phosphate buffered saline (PBS) as a function of time (batch number PC0695042, from Reaction 261/12, Table III)
  • Figure 2 shows the percentage weight gain of the materials with 50% glycerol (based on mol % primary OH) in both deionised water and PBS as a function of time (batch number PC0695041 , from Reaction 261/13, Table IV)
  • Figure 3 shows the percentage weight gain of the materials with 75% glycerol (based on mol % primary OH) in both deionised water and PBS as a function of time (Reaction 261/14, Table IV)
  • Example 6 FTIR Spectroscopy
  • Figure 4 shows the FTIR spectra of the polyester produced from reaction 261/7 from Example 3 (Table IV) and Figure 5 shows that of the reaction product from Reaction 261/10 of Example 3 (Table V).

Abstract

Cross-linked polyester hydrogels, suitable for use as medical implant devices or biodegradable supports for cell cultures used in for example cartilage repair, comprise residues of succinic acid and a polyol having at least three hydroxy groups.

Description

HYDROGELS
The present invention relates to hydrogels. In particular, the present invention relates to polyester hydrogels.
Polyesters of succinic acid are known from US Patent No.3, 883,901. Such polyesters are the reaction product of a succinate ester, such as diethyl succinate, and a glycol, such as polyethylene glycol.
Poly (1 ,4-butanediol succinate) is known from D K Song, Y K Sung, Journal of Applied Polymer Science, 56, 1381 , (1995).
We have now surprisingly found that polyesters produced by reacting succinic anhydride with a polyol containing three or more hydroxy groups are novel and advantageous.
Thus, according to the invention we provide a polyester comprising residues of succinic acid and a polyol containing three or more hydroxy groups.
Thus according to a further feature of the invention we provide a water swellable hydrogel comprising a polyester which polyester comprises residues of succinic acid and a polyol containing three or more hydroxy groups.
By the term a water swellable hydrogel is meant a three- dimensional network of a super absorbent polymer which interacts with aqueous solutions by swelling and retains a significant proportion of water within its structure.
For the purpose of this invention a super absorbent polymer is understood to mean a polymer which is capable of having an equilibrium water content of at least 30% w/w.
We particularly provide a polyester as hereinbefore described with a number average molecular weight (Mn) of greater than (4500), preferably greater than (10,000), and more preferably greater than (20,000).
The high molecular weight polyesters of the invention are also advantageous over prior art polyesters in that they exhibit crosslinking.
Thus as a further feature of the invention we provide a cross-linked polyester of succinic anhydride and a polyol, eg. a cross-linked polyester comprising residues of succinic acid and a polyol containing three or more hydroxy groups. Such cross-linked copolyesters generally act as hydrogels.
Any conventional poiyols containing three or more hydroxy groups known per se are suitable for use in the present invention. Such poiyols include, for example, polyether poiyols or polyhydroxyalkanes. It should be noted that the poiyols for use in the present invention should not be limited to the polyether poiyols or the polyhydroxyalkanes.
Polyhydroxyalkanes of the general formula
cnH(2n+2)On
in which n is a number from 3 to 6,
are suitable for the preparation of the polyester of the invention and include, for example, glycerol, sorbitol, mannitol, adonite, ribite, dulcitol, erythritol and xylite. Poiyols such as triols which may be mentioned include trihydroxyaikanes such as glycerol.
Examples of polyether poiyols include those sold under the range of TP30 by Perstorp.
It is also possible to use a mixture of poiyols which will include mixtures of polyether poiyols or mixtures of polyhydroxyalkanes. Especially preferred are mixtures of polyether poiyols and polyhydroxyalkanes. The polyesters of the invention may be prepared using conventional methods known per se.
Thus according to the invention we provide a method of manufacturing a polyester as hereinbefore described which comprises mixing succinic anhydride and a polyol containing three or more hydroxy groups and drying the mixture at elevated temperature.
The method of manufacturing a polyester according to the invention may optionally include the use of a catalyst. Preferred catalysts are acid catalysts and especially protic acid catalysts. Particular protic acid catalysts which may be mentioned include sulphuric acid, methane sulphonic acid and p-toluene sulphonic acid.
The ratios of the succinic anhydride and the polyol in the polymerisation reaction will depend upon, inter alia, the functionality of the polyol, that is, the number of free hydroxy groups and the degree of cross-linking required in the resulting polyester. Thus if succinic anhydride has a functionality of 2, glycerol, which has two primary and one secondary hydroxy group is also considered to possess a functionality of 2 since the secondary hydroxy is less reactive than the primary hydroxy groups. Defined in terms of functionality the ratio of succinic anhydride to polyol should be from 0.7:1 to 1 :1.3, preferably 1 :1. For example in molar terms a polyester of succinic anhydride and a trioi such as glycerol should comprise preferably 3 units of succinic anhydride to 2 units of glycerol, eg. giving a preferred functionality ratio of 1 :1.
Polyesters according to the invention may be characterised using conventional techniques known per se, such as infra red spectroscopy, nmr, rheological measurements, glass transition measurements and water uptake.
The polyesters according to the invention are particularly advantageous in that they are biodegradable. Thus they may be useful in preparing biodegradable implants such as medical or surgical prostheses, supports for such prostheses, supports for cell cultures such as may be used in ligament, cartilage or tendon repair, supports for cell cultures in woundcare or as woundcare agents in their own right, eg. debnding agents, pharmaceutical carriers etc. or the copolyesters of the invention may be useful in imaging during interventional procedures.
It is intended that the aforementioned uses should not be limitative and are mentioned by way of example only.
The polyesters of the invention are also advantageous in that they are sterilisable. Any conventional form of sterilisation may be used, eg. steam sterilisation, but an especial benefit of the polyesters of the invention is that they may be sterilised without detrimental effect by x-radiation.
Thus according to a further feature of the invention we provide a polyester as hereinbefore described in sterile form, eg. wherein the sterilisation has been carried out by x-radiation.
Polyesters produced from succinic anhydride and diols are known in the prior art to be useful as bioresorbable sutures. Experimental results indicate that such polyesters, as well as the polyesters of the present invention may be especially useful in wound healing, eg. as a debriding agent.
Thus according to the invention we provide the use of a polyester comprising residues of succinic anhydride and a polyol in the manufacture of a wound healing agent, eg. a debriding agent.
According to a further feature of the invention we provide a method of wound healing which comprises applying a polyester comprising residues of succinic acid and a polyol to the wound of a patient.
We especially provide the use of a polyester according to the invention as hereinbefore described. The invention may will be illustrated but in no way limited by way of the following examples and by reference to the Accompanying drawings. Temperatures are stated in degrees celsius.
Example 1
Preparation of Polyesters I
Aliquots of Polyol TP30 (from Perstorp) and succinic anhydride were mixed together in the ratios shown in Table 1 in a closed jar and heated on a hotplate for a few minutes, whilst stirring. A clear solution resulted. One drop of methanesulphonic acid (MSA) was added, and stirring continued for about a minute. Each solution was poured onto the silicone side of a release paper, and placed in a petri dish in a desiccator containing succinic anhydride (3g) and a tray of dried silica gel.
The desiccator was heated in an oven at 80° for 5 to 15 mins with the tap open. It was then heated with the tap closed for a further 15 to 16 hrs at 80°. The resulting materials were heated in a vacuum oven at 70°.
TABLE I
Figure imgf000008_0001
*Succinic acid is considered to have a COOH stoichiometry of 2.
Example 2 Swelling in Water
Several materials resulting from Reaction 1 of Example I (1 :1.3/COOH:OH) were swollen in water. The weight change results after 1 day swelling are shown in Table II.
TABLE II
Figure imgf000008_0002
Example 3
Preparation of Polyesters II
Aliquots of Polyol TP30 and succinic anhydride in the ratios shown in Table III were mixed in a closed glass vessel and heated on an oil bath until a clear solution resulted. Methanesulphonic acid (MSA) was added, and stirring continued for about a minute. The solution was poured into a tray of dried silica gel. When the temperature had equilibrated to 80°, the oven valves were closed, except that one valve was left very slightly open to prevent pressure build-up in the event of thermostat failure. Vacuum was not applied. Products were removed from the oven after 16 hours. TABLE III
Figure imgf000009_0001
A second series of materials were prepared containing various levels of glycerol and TP30. The formulations are shown in Table IV.
TABLE IV
Figure imgf000010_0001
Table V shows the degrees of conversion p(CooH) for these materials, calculated using the method shown below.
Degree of conversion was estimated from the weight loss, ie. water loss, during the reaction using Equation (1) below.
Water loss from the reaction is derived from the following sources:
a) water present in the polyol b) water liberated in the reaction c) water present in the anhydride d) water absorbed from the atmosphere.
c) is assumed to be negligible since the anhydride is stored under nitrogen, though any water absorbed would convert the anhydride to succinic acid and would therefore manifest itself as an error in b). This water would in fact be liberated during the reaction, d) is assumed to be negligible since the reaction is carried out in a sealed system in the presence of a drying agent, followed by vacuum treatment.
a) was calculated from the measured water content of the poiyols.
b) was calculated from the amounts of materials used in the reaction. Since each mole of anhydride gives rise to one mole of water (Figure 1), the total mass of water expected in the reaction mw is given by
mw = mamτ x 18
Mamτ
where
ma is the mass of the anhydride in the mixture (during the initial mixing procedure)
mτ is the total mass of mixture initially prepared
mr is the total mass of mixture poured onto the release paper
Ma is the molecular mass of succinic anhydride.
TABLE V
Figure imgf000012_0001
Example 5
Swelling Measurements a) 0% Glvcerol
Figure 1 shows the percentage weight gain of the materials prepared without glycerol in both deionised water and phosphate buffered saline (PBS) as a function of time (batch number PC0695042, from Reaction 261/12, Table III)
b) 50% Glvcerol
Figure 2 shows the percentage weight gain of the materials with 50% glycerol (based on mol % primary OH) in both deionised water and PBS as a function of time (batch number PC0695041 , from Reaction 261/13, Table IV)
c) 75% Glvcerol
Figure 3 shows the percentage weight gain of the materials with 75% glycerol (based on mol % primary OH) in both deionised water and PBS as a function of time (Reaction 261/14, Table IV) Example 6 FTIR Spectroscopy
Figures 4 and 5 are FTIR spectrographs of two polyesters of the invention. In each case the spectra showed bands characteristic of polyesters, such as ester carbonyl at 1720cm"1 and C=0 stretching around 1300cm"1, together with ether C-O stretching from the ethoxylated polyol at 1100cm"1. Figure 4 shows the FTIR spectra of the polyester produced from reaction 261/7 from Example 3 (Table IV) and Figure 5 shows that of the reaction product from Reaction 261/10 of Example 3 (Table V).

Claims

1. A hydrogel composition comprising a cross-linked polyester containing residues of succinic acid and at least one polyol having at least three hydrogel groups, said composition being adapted to absorb at least 30% of its weight of water.
2. A composition according to claim 1 having an average molecular weight (Mn) of greater than 4500.
3. A composition according to claim 1 or claim 2 wherein the polyol is a polyester polyol, a polyhydroxy alkane or a mixture thereof.
4. A composition according to any one of the preceding claims wherein the polyester is the product of reaction between succinic anhydride and a polyol.
5. A composition according to claim 4 wherein the functionality ratio between succinic anhydride and said polyol is from 0.7:1 to
1 :1.3.
6. A polyester comprising residues derived from succinic anhydrides and at least one polyol having at least 3 hydroxyl groups.
7. A medical device formed for a composition as claimed in any one of claims 1 to 6.
PCT/GB1998/000068 1997-01-11 1998-01-09 Hydrogels WO1998030617A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU55665/98A AU5566598A (en) 1997-01-11 1998-01-09 Hydrogels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9700508.6 1997-01-11
GBGB9700508.6A GB9700508D0 (en) 1997-01-11 1997-01-11 Hydrogels

Publications (1)

Publication Number Publication Date
WO1998030617A1 true WO1998030617A1 (en) 1998-07-16

Family

ID=10805842

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1998/000068 WO1998030617A1 (en) 1997-01-11 1998-01-09 Hydrogels

Country Status (4)

Country Link
AU (1) AU5566598A (en)
GB (1) GB9700508D0 (en)
WO (1) WO1998030617A1 (en)
ZA (1) ZA98167B (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003064496A2 (en) * 2001-10-22 2003-08-07 Massachusetts Institute Of Technology Biodegradable polymer
US7722894B2 (en) 2001-10-22 2010-05-25 Massachusetts Institute Of Technology Biodegradable polymer
USRE43282E1 (en) 1998-09-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and devising treatment
US8143042B2 (en) 2006-01-12 2012-03-27 Massachusetts Institute Of Technology Biodegradable elastomers
US8545569B2 (en) 2001-05-25 2013-10-01 Conformis, Inc. Patient selectable knee arthroplasty devices
US8862202B2 (en) 1998-09-14 2014-10-14 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and preventing damage
US8882847B2 (en) 2001-05-25 2014-11-11 Conformis, Inc. Patient selectable knee joint arthroplasty devices
US8906107B2 (en) 2001-05-25 2014-12-09 Conformis, Inc. Patient-adapted and improved orthopedic implants, designs and related tools
US8912304B2 (en) 2007-05-17 2014-12-16 Massachusetts Institute Of Technology Polyol-based polymers
US8932363B2 (en) 2002-11-07 2015-01-13 Conformis, Inc. Methods for determining meniscal size and shape and for devising treatment
US8951259B2 (en) 2001-05-25 2015-02-10 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US8951260B2 (en) 2001-05-25 2015-02-10 Conformis, Inc. Surgical cutting guide
US8998915B2 (en) 2001-05-25 2015-04-07 Conformis, Inc. Joint arthroplasty devices and surgical tools
US9020788B2 (en) 1997-01-08 2015-04-28 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US9017334B2 (en) 2009-02-24 2015-04-28 Microport Orthopedics Holdings Inc. Patient specific surgical guide locator and mount
US9023050B2 (en) 2001-05-25 2015-05-05 Conformis, Inc. Surgical tools for arthroplasty
US9055953B2 (en) 2001-05-25 2015-06-16 Conformis, Inc. Methods and compositions for articular repair
US9066728B2 (en) 2001-05-25 2015-06-30 Conformis, Inc. Surgical tools facilitating increased accuracy, speed and simplicity in performing joint arthroplasty
US9180015B2 (en) 2008-03-05 2015-11-10 Conformis, Inc. Implants for altering wear patterns of articular surfaces
CN105358185A (en) * 2013-04-10 2016-02-24 墨尔本大学 Biodegradable network polymers for regenerative medicine and tissue engineering
US9286686B2 (en) 1998-09-14 2016-03-15 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and assessing cartilage loss
US9308091B2 (en) 2001-05-25 2016-04-12 Conformis, Inc. Devices and methods for treatment of facet and other joints
US9308053B2 (en) 2006-02-06 2016-04-12 Conformis, Inc. Patient-specific joint arthroplasty devices for ligament repair
US9326780B2 (en) 2006-02-06 2016-05-03 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools incorporating anatomical relief
US9387079B2 (en) 2001-05-25 2016-07-12 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US9486226B2 (en) 2012-04-18 2016-11-08 Conformis, Inc. Tibial guides, tools, and techniques for resecting the tibial plateau
US9495483B2 (en) 2001-05-25 2016-11-15 Conformis, Inc. Automated Systems for manufacturing patient-specific orthopedic implants and instrumentation
US9579110B2 (en) 2001-05-25 2017-02-28 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9603711B2 (en) 2001-05-25 2017-03-28 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US9642632B2 (en) 2009-02-24 2017-05-09 Microport Orthopedics Holdings Inc. Orthopedic surgical guide
US9649117B2 (en) 2009-02-24 2017-05-16 Microport Orthopedics Holdings, Inc. Orthopedic surgical guide
US9675471B2 (en) 2012-06-11 2017-06-13 Conformis, Inc. Devices, techniques and methods for assessing joint spacing, balancing soft tissues and obtaining desired kinematics for joint implant components
US9700971B2 (en) 2001-05-25 2017-07-11 Conformis, Inc. Implant device and method for manufacture
US10085839B2 (en) 2004-01-05 2018-10-02 Conformis, Inc. Patient-specific and patient-engineered orthopedic implants

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6031802B2 (en) * 1978-03-22 1985-07-24 日清製油株式会社 cosmetics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6031802B2 (en) * 1978-03-22 1985-07-24 日清製油株式会社 cosmetics

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 104, no. 12, 24 March 1986, Columbus, Ohio, US; abstract no. 95260, HIGAKI ET AL.: "Novel, hydrophilic polyol esters for hair preparations" XP002061206 *
CHEN ET AL.: "Enzymatic and chemoenzymatic approaches to synthesis of sugar-based polymer and hydrogels", CARBOHYDRATE POLYMERS., vol. 28, no. 1, 1995, BARKING GB, pages 15 - 21, XP000539360 *

Cited By (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9020788B2 (en) 1997-01-08 2015-04-28 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US8862202B2 (en) 1998-09-14 2014-10-14 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and preventing damage
US9286686B2 (en) 1998-09-14 2016-03-15 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and assessing cartilage loss
USRE43282E1 (en) 1998-09-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and devising treatment
US9295482B2 (en) 2001-05-25 2016-03-29 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9877790B2 (en) 2001-05-25 2018-01-30 Conformis, Inc. Tibial implant and systems with variable slope
US8690945B2 (en) 2001-05-25 2014-04-08 Conformis, Inc. Patient selectable knee arthroplasty devices
US8545569B2 (en) 2001-05-25 2013-10-01 Conformis, Inc. Patient selectable knee arthroplasty devices
US9775680B2 (en) 2001-05-25 2017-10-03 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US8882847B2 (en) 2001-05-25 2014-11-11 Conformis, Inc. Patient selectable knee joint arthroplasty devices
US8906107B2 (en) 2001-05-25 2014-12-09 Conformis, Inc. Patient-adapted and improved orthopedic implants, designs and related tools
US9700971B2 (en) 2001-05-25 2017-07-11 Conformis, Inc. Implant device and method for manufacture
US8926706B2 (en) 2001-05-25 2015-01-06 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US9603711B2 (en) 2001-05-25 2017-03-28 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US8945230B2 (en) 2001-05-25 2015-02-03 Conformis, Inc. Patient selectable knee joint arthroplasty devices
US9308091B2 (en) 2001-05-25 2016-04-12 Conformis, Inc. Devices and methods for treatment of facet and other joints
US8951260B2 (en) 2001-05-25 2015-02-10 Conformis, Inc. Surgical cutting guide
US9579110B2 (en) 2001-05-25 2017-02-28 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US8974539B2 (en) 2001-05-25 2015-03-10 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US8998915B2 (en) 2001-05-25 2015-04-07 Conformis, Inc. Joint arthroplasty devices and surgical tools
US9495483B2 (en) 2001-05-25 2016-11-15 Conformis, Inc. Automated Systems for manufacturing patient-specific orthopedic implants and instrumentation
US9439767B2 (en) 2001-05-25 2016-09-13 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US9023050B2 (en) 2001-05-25 2015-05-05 Conformis, Inc. Surgical tools for arthroplasty
US9055953B2 (en) 2001-05-25 2015-06-16 Conformis, Inc. Methods and compositions for articular repair
US9066728B2 (en) 2001-05-25 2015-06-30 Conformis, Inc. Surgical tools facilitating increased accuracy, speed and simplicity in performing joint arthroplasty
US9072531B2 (en) 2001-05-25 2015-07-07 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9084617B2 (en) 2001-05-25 2015-07-21 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9387079B2 (en) 2001-05-25 2016-07-12 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US9107680B2 (en) 2001-05-25 2015-08-18 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9107679B2 (en) 2001-05-25 2015-08-18 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9358018B2 (en) 2001-05-25 2016-06-07 Conformis, Inc. Joint arthroplasty devices and surgical tools
US9125673B2 (en) 2001-05-25 2015-09-08 Conformis, Inc. Joint arthroplasty devices and surgical tools
US9125672B2 (en) 2001-05-25 2015-09-08 Conformis, Inc. Joint arthroplasty devices and surgical tools
US9333085B2 (en) 2001-05-25 2016-05-10 Conformis, Inc. Patient selectable knee arthroplasty devices
US9186254B2 (en) 2001-05-25 2015-11-17 Conformis, Inc. Patient selectable knee arthroplasty devices
US9186161B2 (en) 2001-05-25 2015-11-17 Conformis, Inc. Surgical tools for arthroplasty
US9216025B2 (en) 2001-05-25 2015-12-22 Conformis, Inc. Joint arthroplasty devices and surgical tools
US8951259B2 (en) 2001-05-25 2015-02-10 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
WO2003064496A3 (en) * 2001-10-22 2004-02-12 Massachusetts Inst Technology Biodegradable polymer
WO2003064496A2 (en) * 2001-10-22 2003-08-07 Massachusetts Institute Of Technology Biodegradable polymer
US7722894B2 (en) 2001-10-22 2010-05-25 Massachusetts Institute Of Technology Biodegradable polymer
US8965088B2 (en) 2002-11-07 2015-02-24 Conformis, Inc. Methods for determining meniscal size and shape and for devising treatment
US8932363B2 (en) 2002-11-07 2015-01-13 Conformis, Inc. Methods for determining meniscal size and shape and for devising treatment
US10085839B2 (en) 2004-01-05 2018-10-02 Conformis, Inc. Patient-specific and patient-engineered orthopedic implants
US11458230B2 (en) 2006-01-12 2022-10-04 Massachusetts Institute Of Technology Method comprising contacting tissue with a cross-linkable polyester prepolymer
US10179195B2 (en) 2006-01-12 2019-01-15 Massachusetts Institue Of Technology Method comprising contacting tissue with a cross-linkable polyester prepolymer
US10864303B2 (en) 2006-01-12 2020-12-15 Massachusetts Institute Of Technology Method comprising contacting tissue with a cross-linkable polyester prepolymer
US8691203B2 (en) 2006-01-12 2014-04-08 Massachusetts Institute Of Technology Method comprising contacting tissue with a cross-linkable polyester prepolymer
US8143042B2 (en) 2006-01-12 2012-03-27 Massachusetts Institute Of Technology Biodegradable elastomers
US9326780B2 (en) 2006-02-06 2016-05-03 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools incorporating anatomical relief
US9308053B2 (en) 2006-02-06 2016-04-12 Conformis, Inc. Patient-specific joint arthroplasty devices for ligament repair
US9220517B2 (en) 2006-02-06 2015-12-29 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US9220516B2 (en) 2006-02-06 2015-12-29 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
US8912304B2 (en) 2007-05-17 2014-12-16 Massachusetts Institute Of Technology Polyol-based polymers
US9180015B2 (en) 2008-03-05 2015-11-10 Conformis, Inc. Implants for altering wear patterns of articular surfaces
US9700420B2 (en) 2008-03-05 2017-07-11 Conformis, Inc. Implants for altering wear patterns of articular surfaces
US9017334B2 (en) 2009-02-24 2015-04-28 Microport Orthopedics Holdings Inc. Patient specific surgical guide locator and mount
US11154305B2 (en) 2009-02-24 2021-10-26 Microport Orthopedics Holdings Inc. Patient specific surgical guide locator and mount
US9675365B2 (en) 2009-02-24 2017-06-13 Microport Orthopedics Holdings Inc. System and method for anterior approach for installing tibial stem
US9649117B2 (en) 2009-02-24 2017-05-16 Microport Orthopedics Holdings, Inc. Orthopedic surgical guide
US11779347B2 (en) 2009-02-24 2023-10-10 Microport Orthopedics Holdings Inc. System for forming a patient specific surgical guide mount
US9642632B2 (en) 2009-02-24 2017-05-09 Microport Orthopedics Holdings Inc. Orthopedic surgical guide
US9566075B2 (en) 2009-02-24 2017-02-14 Microport Orthopedics Holdings Inc. Patient specific surgical guide locator and mount
US9883870B2 (en) 2009-02-24 2018-02-06 Microport Orthopedics Holdings Inc. Method for forming a patient specific surgical guide mount
US9901353B2 (en) 2009-02-24 2018-02-27 Microport Holdings Inc. Patient specific surgical guide locator and mount
US9949747B2 (en) 2009-02-24 2018-04-24 Microport Orthopedics Holdings, Inc. Systems and methods for installing an orthopedic implant
US10039557B2 (en) 2009-02-24 2018-08-07 Micorport Orthopedics Holdings, Inc. Orthopedic surgical guide
US11911046B2 (en) 2009-02-24 2024-02-27 Microport Orthopedics Holdings, Inc. Patient specific surgical guide locator and mount
US9089342B2 (en) 2009-02-24 2015-07-28 Microport Orthopedics Holdings Inc. Patient specific surgical guide locator and mount
US11779356B2 (en) 2009-02-24 2023-10-10 Microport Orthopedics Holdings, Inc. Orthopedic surgical guide
US10512476B2 (en) 2009-02-24 2019-12-24 Microport Orthopedics Holdings, Inc. Orthopedic surgical guide
US9113914B2 (en) 2009-02-24 2015-08-25 Microport Orthopedics Holdings Inc. Method for forming a patient specific surgical guide mount
US10660654B2 (en) 2009-02-24 2020-05-26 Microport Orthopedics Holdings Inc. Method for forming a patient specific surgical guide mount
US10646238B2 (en) 2009-02-24 2020-05-12 Microport Orthopedics Holdings, Inc. Systems and methods for installing an orthopedic implant
US10973536B2 (en) 2009-02-24 2021-04-13 Microport Orthopedics Holdings, Inc. Orthopedic surgical guide
US11534186B2 (en) 2009-02-24 2022-12-27 Microport Orthopedics Holdings Inc. Orthopedic surgical guide
US11389177B2 (en) 2009-02-24 2022-07-19 Microport Orthopedics Holdings Inc. Method for forming a patient specific surgical guide mount
US9320620B2 (en) 2009-02-24 2016-04-26 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US11464527B2 (en) 2009-02-24 2022-10-11 Microport Orthopedics Holdings Inc. Systems and methods for installing an orthopedic implant
US9486226B2 (en) 2012-04-18 2016-11-08 Conformis, Inc. Tibial guides, tools, and techniques for resecting the tibial plateau
US9675471B2 (en) 2012-06-11 2017-06-13 Conformis, Inc. Devices, techniques and methods for assessing joint spacing, balancing soft tissues and obtaining desired kinematics for joint implant components
US10179834B2 (en) 2013-04-10 2019-01-15 The University Of Melbourne Biodegradable network polymers for regenerative medicine and tissue engineering
CN105358185A (en) * 2013-04-10 2016-02-24 墨尔本大学 Biodegradable network polymers for regenerative medicine and tissue engineering

Also Published As

Publication number Publication date
ZA98167B (en) 1998-07-13
AU5566598A (en) 1998-08-03
GB9700508D0 (en) 1997-02-26

Similar Documents

Publication Publication Date Title
WO1998030617A1 (en) Hydrogels
Daemi et al. A robust super-tough biodegradable elastomer engineered by supramolecular ionic interactions
US5644002A (en) Absorbable polyalkylene diglycolates
US7498385B2 (en) Polyester compositions, methods of manufacturing said compositions, and articles made therefrom
JP3739501B2 (en) Absorbed and biologically compatible segmented copolymer and process for its production
JP3428807B2 (en) Absorbable polyoxaester
JP5351516B2 (en) Chain extender
US5688900A (en) Absorbable polyalkylene diglycolates
US6699940B2 (en) Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom
US20040068078A1 (en) In situ polymerizing medical compositions
JPH1053642A (en) Absorbable polyoxaester
JPH10158377A (en) Hydrogel of amine and/or amido group-containing absorbable polyoxaester
KR20020032555A (en) Method of preventing adhesions with absorbable polyoxaesters
AU741741B2 (en) Polyesterhydrogels
JP2000509084A (en) Polyester ionomer for implant production
JPH10158375A (en) Hydrogel of absorbable polyoxaester
KR102208921B1 (en) Shape memory polymer, preparation method thereof, and the use of the same
EP1874525A1 (en) Hydrophilic/hydrophobic polymer networks based on poly(caprolactone fumarate), poly(ethylene glycol fumarate), and copolymers thereof
Jabbari et al. Synthesis and characterization of bioresorbable in situ crosslinkable ultra low molecular weight poly (lactide) macromer
WO2004021983A2 (en) In situ polymerizing medical compositions
Andjelić et al. The polyoxaesters
MXPA97001689A (en) Absorbib polioxaesters
MXPA97001991A (en) Copolymer and absorbable mixes of 6,6-dialquil-1,4-dioxepan-2-ona and its dimero cicl

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998530658

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase